Management of HBV reactivation in non-oncological patients
Mariantonietta Pisaturo(University of Antwerp), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Federica Portunato(Ospedale Policlinico San Martino), Giovanni Di Caprio(Ospedale Sant'Anna), Salvatore Martini(University of Campania "Luigi Vanvitelli"), Federica Calò
Cited by 10
Related Papers
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
|Diabetes & Metabolism|2020|138
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
|PLoS ONE|2020|128
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy
|Clinical Microbiology and Infection|2020|104
Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories
|Journal of Hepatology|2023|94